{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&hansardHeading=Human+Papillomavirus%3A+Vaccination", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health&hansardHeading=Human+Papillomavirus%3A+Vaccination", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_metadata=all&hansardHeading=Human+Papillomavirus%3A+Vaccination", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&_page=0&hansardHeading=Human+Papillomavirus%3A+Vaccination", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&hansardHeading=Human+Papillomavirus%3A+Vaccination", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health&hansardHeading=Human+Papillomavirus%3A+Vaccination", "items" : [{"_about" : "http://data.parliament.uk/resources/816729", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/816729/answer", "answerText" : {"_value" : "
The Joint Committee on Vaccination and Immunisation (JCVI) is updating its advice on the potential extension of the human papillomavirus vaccination programme to include adolescent boys.<\/p>
<\/p>
An assessment of the overall costs of expanding the programme will be completed once JCVI\u2019s final advice is received.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2018-01-15", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2018-01-15T11:58:22.007Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2018-01-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health, what assessment his Department has made of the cost of extending the HPV vaccine to teenage boys.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4653", "label" : {"_value" : "Biography information for Stephen Morgan"} } , "tablingMemberConstituency" : {"_value" : "Portsmouth South"} , "tablingMemberPrinted" : [{"_value" : "Stephen Morgan"} ], "uin" : "121156"} , {"_about" : "http://data.parliament.uk/resources/802408", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/802408/answer", "answerText" : {"_value" : "
The Global Advisory Committee on Vaccine Safety (GACVS) provides independent, authoritative, scientific advice to the World Health Organization (WHO) on vaccine safety issues. The GACVS public summary report dated 14 July 2017 states that it was presented with a draft of a systematic review of serious adverse events following human papillomavirus (HPV) vaccines that had been commissioned by WHO and summarises its findings. This found no difference in rates of selected serious adverse events between those exposed and unexposed to HPV vaccine. A copy of the systematic review, Serious adverse events associated with HPV vaccination<\/em>, is attached.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/802408/answer/attachment/1", "fileName" : {"_value" : "HPV vaccination safety report _AHTA dec17.pdf"}
, "title" : "Serious adverse events associated with HPV"}
, "dateOfAnswer" : {"_value" : "2017-12-20", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-12-20T16:54:10.813Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-12-06", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 5 December (HL3500), whether they will place a copy of the systematic review of serious adverse reactions following HPV vaccines, commissioned by the World Health Organisation, in the Library of the House.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
}
, "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
], "uin" : "HL3941"}
, {"_about" : "http://data.parliament.uk/resources/793538", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/793538/answer", "answerText" : {"_value" : " The World Health Organization\u2019s Global Advisory Committee on Vaccine Safety publishes a summary outcome of its vaccine safety reviews on a six-monthly basis. The outcome of the Committee\u2019s most recent review of human papillomavirus (HPV) vaccine safety was published on 14 July 2017. A copy of the Weekly epidemiological record<\/em> is attached, which summarises the latest six month review. This review found no new adverse events of concern for HPV vaccine based on many very large, high quality studies.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "attachment" : {"_about" : "http://data.parliament.uk/resources/793538/answer/attachment/1", "fileName" : {"_value" : "GACVS 14 Jul 2017.pdf"}
, "title" : "Weekly epidemiological record"}
, "dateOfAnswer" : {"_value" : "2017-12-05", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-12-05T11:55:14.383Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-11-22", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government whether they intend to place a copy of the systematic review of serious adverse reactions following HPV vaccines, commissioned by the World Health Organisation, in the Library of the House.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
}
, "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
], "uin" : "HL3500"}
, {"_about" : "http://data.parliament.uk/resources/788917", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/788917/answer", "answerText" : {"_value" : " We have made no assessment of vaccine damage awards for human papillomavirus (HPV) vaccine in the United States as this is a matter for the US courts.<\/p> Thorough reviews undertaken by national and international scientific bodies have found no evidence to support a link between HPV vaccine and the development of chronic illnesses.<\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"}
}
, "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"}
, "dateOfAnswer" : {"_value" : "2017-11-27", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2017-11-27T13:09:58.437Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health"}
, "answeringDeptSortName" : {"_value" : "Health"}
, "date" : {"_value" : "2017-11-14", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Human Papillomavirus: Vaccination"}
, "houseId" : {"_value" : "2"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
}
], "questionText" : "To ask Her Majesty's Government, further to the Written Answer by Lord O'Shaughnessy on 2 November (HL2355) that no link has been established between HPV vaccines and chronic illness, what assessment they have made of the awards for damages made by the US Vaccine Court to 38 of 58 cases on this issue since 2016.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/1861", "label" : {"_value" : "Biography information for The Countess of Mar"}
}
, "tablingMemberPrinted" : [{"_value" : "The Countess of Mar"}
], "uin" : "HL3226"}
, {"_about" : "http://data.parliament.uk/resources/786831", "AnsweringBody" : [{"_value" : "Department of Health"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/786831/answer", "answerText" : {"_value" : " The Joint Committee on Vaccination and Immunisation (JCVI) met on 4 October 2017 and discussed the responses from stakeholders to JCVI\u2019s interim advice on whether to extend the human papilloma virus vaccination to boys. The minutes of 4 October JCVI meeting will be published on 15 November 2017 at:<\/p>